Search Results - "Sendi, Hossein"

Refine Results
  1. 1

    Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis by Sendi, Hossein, Yazdimamaghani, Mostafa, Hu, Mengying, Sultanpuram, Nikhila, Wang, Jie, Moody, Amber S, McCabe, Ellie, Zhang, Jiajie, Graboski, Amanda, Li, Liantao, Rojas, Juan D, Dayton, Paul A, Huang, Leaf, Wang, Andrew Z

    Published in Cancer research (Chicago, Ill.) (01-01-2022)
    “…Liver metastasis is a leading cause of cancer morbidity and mortality. Thus, there has been strong interest in the development of therapeutics that can…”
    Get full text
    Journal Article
  2. 2

    The role of liver microenvironment in hepatic metastasis by Williamson, Tovah, Sultanpuram, Nikhila, Sendi, Hossein

    Published in Clinical and translational medicine (01-07-2019)
    “…Metastasis is still poorly understood and thus further research must be conducted to provide insight into the driving factors. Novel research has revealed the…”
    Get full text
    Journal Article
  3. 3

    Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis by Sendi, Hossein

    Published in Hepatitis monthly (01-05-2012)
    “…The hepatic microRNA (miRNA), miR-122, is the most abundant miRNA within the liver, where it accounts for 70% of the total miRNA pool. It is known that…”
    Get full text
    Journal Article
  4. 4

    miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling by Sendi, Hossein, Mead, Ivy, Wan, Meimei, Mehrab-Mohseni, Marjan, Koch, Kenneth, Atala, Anthony, Bonkovsky, Herbert L, Bishop, Colin E

    Published in PloS one (19-07-2018)
    “…To investigate the role of miR-122 in the development and regression of non-alcoholic fatty liver disease (NAFLD) in vitro, we used multicellular 3D human…”
    Get full text
    Journal Article
  5. 5

    Hepatitis C, porphyria cutanea tarda and liver iron: an update by Ryan Caballes, F., Sendi, Hossein, Bonkovsky, Herbert L.

    Published in Liver international (01-07-2012)
    “…Porphyria cutanea tarda (PCT) is the most common form of porphyria across the world. Unlike other forms of porphyria, which are inborn errors of metabolism,…”
    Get full text
    Journal Article
  6. 6

    Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome by Ghaziani, Tahereh, Sendi, Hossein, Shahraz, Saeid, Zamor, Philippe, Bonkovsky, Herbert L

    Published in World journal of gastroenterology : WJG (21-10-2014)
    “…Hepatitis B virus(HBV) continues to be a major cause of morbidity and mortality worldwide. It is estimated that about 350 million people throughout the world…”
    Get full text
    Journal Article
  7. 7

    Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV by Mehrab-Mohseni, Marjan, Sendi, Hossein, Steuerwald, Nury, Ghosh, Sriparna, Schrum, Laura W, Bonkovsky, Herbert L

    Published in World journal of gastroenterology : WJG (07-04-2011)
    “…AIM: To determine the effect of Legalon-SIL (LS) on hepatitis C virus (HCV) core and NS5A expression and on heme oxygenase-1 (HMOX-1) and its transcriptional…”
    Get full text
    Journal Article
  8. 8

    Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection by Ghaziani, Tahereh, Alavian, Seyed-Moayed, Zali, Mohammad R., Shahraz, Saeid, Agah, Mohammdreza, Jensen, Kevin P., Ansari, Shahin, Sendi, Hossein, Lambrecht, Richard W., Covault, Jonathan, Bonkovsky, Herbert L.

    Published in Hepatology research (01-03-2007)
    “…Aim:  We tested associations between HFE mutations and hepatitis B virus (HBV) infection. We also explored measures of total body iron status and their…”
    Get full text
    Journal Article
  9. 9

    Abstract 5033: Targeted delivery of miR-122 into hepatocytes regresses liver metastasis by Sendi, Hossein, Sultanpuram, Nikhila, Wang, Jie, Graboski, Amanda, Li, Liantao, Hu, Mengying, Huang, Leaf, Wang, Andrew Z.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background: Metastatic tumors in the liver are 20 times more common than primary tumors and considered as a leading cause of mortality in several…”
    Get full text
    Journal Article
  10. 10

    Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo by Yang, Feifei, Medik, Yusra, Li, Liantao, Tian, Xi, Fu, Dong, Brouwer, Kim L. R., Wagner, Kyle, Sun, Bo, Sendi, Hossein, Mi, Yu, Wang, Andrew Z.

    “…Hepatotoxicity is a key concern in the clinical translation of nanotherapeutics because preclinical studies have consistently shown that nanotherapeutics…”
    Get full text
    Journal Article
  11. 11

    Abstract 281: Culture of circulating tumor cells isolated from cancer patients with metastatic disease by Sultanpuram, Nikhila Reddy, Kim, Isaiah, Sendi, Hossein, Kanpe, Nicole, Hagen, Tilden, Wagner, Kyle, Wang, Andrew

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract OBJECTIVE: The purpose of this study is to investigate the feasibility of using decellularized tissue ECM to culture circulating tumor cells (CTCs)…”
    Get full text
    Journal Article
  12. 12

    CCR5 [Delta] 32 mutation is not prevalent in Iranians with chronic HBV infection by Khorramdelazad, Hossein, Hakimizadeh, Elham, Hassanshahi, Gholamhossein, Rezayati, Mohammadtaghi, Sendi, Hossein, Arababadi, Mohammad Kazemi

    Published in Journal of medical virology (01-06-2013)
    “…CCR5 is an important chemokine receptor involved in the recruitment of specific anti-viral immune cells (e.g., NK cells and T cytotoxic cells) to the liver…”
    Get full text
    Journal Article
  13. 13

    CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection by Khorramdelazad, Hossein, Hakimizadeh, Elham, Hassanshahi, Gholamhossein, Rezayati, Mohammadtaghi, Sendi, Hossein, Arababadi, Mohammad Kazemi

    Published in Journal of medical virology (01-06-2013)
    “…CCR5 is an important chemokine receptor involved in the recruitment of specific anti‐viral immune cells (e.g., NK cells and T cytotoxic cells) to the liver…”
    Get full text
    Journal Article
  14. 14
  15. 15

    miR-122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA by Sendi, Hossein, Mehrab-Mohseni, Marjan, Foureau, David M., Ghosh, Sriparna, Walling, Tracy L., Steuerwald, Nury, Zamor, Philippe J., Kaplan, Keith J., Jacobs, Carl, Ahrens, William A., Russo, Mark W., Clemens, Mark G., Schrum, Laura W., Bonkovsky, Herbert L.

    Published in Liver international (01-04-2015)
    “…Background & Aims Analysis in silico suggests that occludin (OCLN), a key receptor for HCV, is a candidate target of miR‐122; the most abundant hepatic micro…”
    Get full text
    Journal Article
  16. 16

    Novel roles of microRNAs in hepatitis C by Sendi, Hossein

    Published 01-01-2013
    “…Approximately, 170 million people are infected by hepatitis C virus (HCV) worldwide, and of these, nearly 85% will develop chronic hepatitis C (CHC). Despite…”
    Get full text
    Dissertation
  17. 17
  18. 18
  19. 19

    CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA by Sendi, Hossein, Mehrab-Mohseni, Marjan, Shahraz, Saeid, Norder, Helene, Alavian, Seyed-Moayed, Noorinayer, Babak, Zali, Mohammad R, Pumpens, Paul, Bonkovsky, Herbert L, Magnius, Lars O

    Published in Journal of clinical virology (01-11-2009)
    “…Abstract Background Recent studies have suggested that Cytotoxic T lymphocytes (CTL) play a key role in eliminating hepatitis B virus (HBV). Objectives We…”
    Get full text
    Journal Article
  20. 20